WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results